祥生医疗股票讨论区

Despite Chison Medical Technologies' superior earnings outlook and faster-than-market growth, it trades at a lower P/E, suggesting investors doubt its future growth. Potential risks and earnings instability may be pressuring the P/E ratio.

Due to the decreasing trend in ROCE and low stock returns of 7.5% over three years, it may not be the best option for investors seeking high returns.